Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Oliva

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Pediatrics|October 27, 2007
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohortsSubra Kugathasan, Justin Nebel, Joseph A Skelton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2006
The natural history of corticosteroid therapy for ulcerative colitis in childrenJeffrey Hyams, James Markowitz, Trudy Lerer, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2009
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigmsMarian Pfefferkorn, Georgine Burke, Anne Griffiths, et al.
The American Journal of Gastroenterology|January 28, 2010
Outcome following infliximab therapy in children with ulcerative colitisJeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Inflammatory Bowel Diseases|February 29, 2008
Effect of early immunomodulator use in moderate to severe pediatric Crohn diseaseJaya Punati, James Markowitz, Trudy Lerer, et al.
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Pediatrics|October 27, 2007
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohortsSubra Kugathasan, Justin Nebel, Joseph A Skelton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2006
The natural history of corticosteroid therapy for ulcerative colitis in childrenJeffrey Hyams, James Markowitz, Trudy Lerer, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2009
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigmsMarian Pfefferkorn, Georgine Burke, Anne Griffiths, et al.
The American Journal of Gastroenterology|January 28, 2010
Outcome following infliximab therapy in children with ulcerative colitisJeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Inflammatory Bowel Diseases|February 29, 2008
Effect of early immunomodulator use in moderate to severe pediatric Crohn diseaseJaya Punati, James Markowitz, Trudy Lerer, et al.
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
Pageof 15